Baxter and Momenta Form Global Collaboration to Develop and Commercialise Biosimilars

By Heather Cartwright

Pharma Deals Review: Vol 2012 Issue 1 (Table of Contents)

Published: 13 Jan-2012

DOI: 10.3833/pdr.v2012.i1.1668     ISSN: 1756-7874

Section: Research & Development



Deals for the development and commercialisation of biosimilars have risen in prominence of late with the latest such deal being a global collaboration between Baxter International and Momenta Pharmaceuticals that covers up to six follow-on biologics...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details